FindTrial
Sign In

Buprenorphine as an adjuvant to levobupivacaine in lumbar plexus block for postoperative pain relief after hip, thigh and knee surgeries

A comparative study of buprenorphine in two different doses as an adjuvant to levobupivacaine in USG guided unilateral lumbar plexus block for postoperative analgesia after hip, thigh and knee surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011437
Enrollment
90
Registered
2018-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients posted for hip & thigh surgeries under spinal Anesthesia having ASA Grade I & II

Interventions

Intervention1: Lumbar Plexus Block: Lumbar Plexus Block will be administered to patient after the surgery when level of subarachnoid block has receded to T10 level Control Intervention1: Levobupivacai

Sponsors

Dr RPGMC Kangra at Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. scheduled for hip, thigh and knee surgery under subarachnoid block. 2. ASA class I-II. 3. BMI 18.5-29.9.

Exclusion criteria

Exclusion criteria: 1. Patientâ??s refusal either for spinal anesthesia or for lumbar plexus block. 2. Patients with anatomical deformities. 3. Patients having bleeding disorders. 4. Patients with local infection at the sites where needle for spinal and lumbar plexus block is to be inserted. 5. Patients having dysrhythmias on the ECG 6. Patients allergic to study drugs. 7. Patients who are opioid tolerant or opioid dependent. 8. Patients on anticoagulants. 9. Failure of spinal anesthesia.

Design outcomes

Primary

MeasureTime frame
To study and compare post-operative analgesia with two different doses of buprenorphineTimepoint: 24 hours—

Secondary

MeasureTime frame
Duration of analgesiaTimepoint: 24 hours;Modified Ramsay Sedation ScoreTimepoint: 24 hours;Nausea and VomitingTimepoint: 24 hours;Patient Satisfaction ScoreTimepoint: 24 hours—

Countries

India

Contacts

Public ContactVaibhav Tulsyan

Dr. Rajendra Prasad Government Medical College, Kangra at Tanda

drjaisingh62@gmail.com9418070893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026